The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players

Detailed TOC of The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players

Table of Contents
Introduction 
What is the Mid-Sized Pharma Segment and What is its Role in the Industry?
Why is Mid-size Pharma a Key Element of the Industry?
Mid-size Pharma Players with Revenue Forecasts
Comparative Analysis and Ranking - Based on
Revenue
R&D Expenditure
Number of Pipeline Products
Number of Marketed Products
Number of Employees
Location of Headquarter
Year-on-Year Revenue
Year-on-Year R&D Expenditure
Key Points
Mid-size Pharma Companies - Growth Strategies related to Deals and Collaborations 
Mergers and Acquisitions
Licensing Agreements and Partnerships
R&D Collaboration
Geographical Expansion
In-House Research and Development
Shift towards High-Value Generics from Low-Value Generics
Brand Building
Specialized Therapy Areas and Rare Diseases
Key Points
Top Mid-size Pharma Companies
Daiichi Sankyo
Valeant Pharmaceuticals
Eisai
Regeneron Pharmaceuticals
UCB
Les Laboratories Servier
Sun Pharmaceutical
Endo International
Mallinckrodt
Kyowa Hakko Kirin
Alexion Pharmaceuticals
Taisho Pharmaceutical
Overview
Top Marketed Products
Pipeline Overview
Late stage Products with Sales Forecast
Revenue Forecast
Deals by Value and Volume
Key Deals
Top Small Pharma Companies Likely to Enter the Mid-size Segment
Horizon Pharma
Intas Pharmaceuticals
Hypermarcas
Challenges Faced by Mid-size Pharma
Conclusion
List of Mid-size Pharma Companies
Bibliography
Disclaimer